Annals of Hematology

Aims & Scope

A forum for clinical and experimental hematology, hemostaseology, blood transfusion, and related aspects of hematological oncology Also covers diagnosis and treatment of leukemias, lymphatic neoplasias and transplantation of hematopoietic stem cells Examines relevant aspects of oncology, molecular biology and immunology 100% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again Annals of Hematology covers the whole spectrum of clinical and translational hematology, hemostaseology, blood transfusion, and related aspects of medical oncology, including diagnosis and treatment of leukemias, lymphatic neoplasias and transplantation of hematopoietic stem cells.

Coverage includes general aspects of oncology, molecular biology and immunology as pertinent to problems of human blood disease.

The journal is associated with the German Society for Hematology and Medical Oncology, and the Austrian Society for Hematology and Oncology.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	2.4
2024	3.00

Journal Rank

Year	Value
2024	6085

Journal Citation Indicator

Year	Value
2024	2326

SJR (SCImago Journal Rank)

Year	Value
2024	0.862

Quartile

Year	Value
2024	Q2

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Mechanism of thrombocytopenia in COVID-19 patients

  Citation: 402

  Authors: Panyang, Qi, Jiancheng

• Epidemiology of non-Hodgkin?s lymphoma (NHL): trends, geographic distribution, and etiology

  Citation: 355

  Authors: Antonia M. S., Gabriele, Roland, Monika

• The IgG Fc receptor family

  Citation: 307

  Authors: J. E., H., A., R. E.

• Blood type and outcomes in patients with COVID-19

  Citation: 253

  Authors: Christopher A., Charles, Laura, C. Y. Maximilian, Rushad, Mark F., Matthew, Anahita

• Apoptosis: mechanisms and relevance in cancer

  Citation: 250

  Authors: Katrien, Dirk R., Zwi N.

• Donor age and long-term culture affect differentiation and proliferation of human bone marrow mesenchymal stem cells

  Citation: 247

  Authors: Merve, Serap, Guven, Sevim

• Copper deficiency anemia: review article

  Citation: 228

  Authors: Zin W., Thein H., Kyaw Z., Aung M., Hayder

• Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States

  Citation: 227

  Authors: Bruno C., Sacha, Deborah, Khang Q., Faiyaz, Carolina

• Postpartum anemia I: definition, prevalence, causes, and consequences

  Citation: 199

  Authors: Nils

• Antimicrobial therapy of unexplained fever in neutropenic patients

  Citation: 187

  Authors: H., A., O. A., K., O., W. V., R., G., M. R., H., M., O., X., M., H. W.

---